Centessa Pharmaceuticals plc

NASDAQ:CNTA

17.16 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -42.566-43.816-38.046-37.157-38.648-24.886-50.714-43.173-53.875-64.661-54.498-60.911-39.975-41.37-240.288-3.286-2.138-2.228-3.011
Depreciation & Amortization 0.2360.2360.240.2480.2380.2370.0890.0360.0350.0320.0280.0120.0130.0070.0020000
Deferred Income Tax 1.2540.5670.434-0.135-2.89-23.6390-2.857-0.1350000000000
Stock Based Compensation 8.4538.6118.1547.437.5597.2137.196.6177.0275.6035.7184.7594.1333.2292.7310.0910.0290.090.063
Change In Working Capital 11.804-5.888-9.168-3.445-4.446-5.661-5.378-14.0437.066.497-2.345-1.94-0.138-6.9823.683-0.409-0.2450.366-0.209
Accounts Receivables 9.84301.209-7.964-2.329-6.1924.345-3.937-2.4980.427-5.6953.481-5.086-3.26-1.8560000
Change In Inventory 00002.3296.192-9.7233.9372.498-0.427000000000
Change In Accounts Payables 1.706-2.188-4.250.590.083-1.576-1.8152.5963.1321.843-1.224.1570000000
Other Working Capital 0.255-3.7-6.1273.928-4.529-4.0851.815-16.6393.9284.654-1.125-5.4224.947-3.7225.539-0.409-0.2450.366-0.209
Other Non Cash Items -0.57-0.291.11.9590.7952.6740.9751.8560.8-7.3481.083.09311.89217.745225.7980.3230.459-0.043-0.482
Operating Cash Flow -21.389-40.58-37.286-31.101-37.392-44.062-47.838-51.564-39.088-59.877-50.017-56.289-33.32-33.867-12.666-3.281-1.895-1.815-3.639
Investing Activities:
Investments In Property Plant And Equipment -0.0340-0-0.028-0.043-0.01-0.088-0.652-0.016-0.229-0.24-0.064-0.048-0.037-0.0370000
Acquisitions Net 00018.247-86.629000000-0.1540.1-0.28663.7740000
Purchases Of Investments 146.834-120.534-19.999-70.24-37.499-71.089-86.248000000000000
Sales Maturities Of Investments 44.99865.12836.76151.98186.62900000000000000
Other Investing Activites -146.834-0.05316.762-18.24786.248-71.089-86.2480.2060004.5960-0.112-4.4840000
Investing Cash Flow 44.964-55.45916.762-18.28748.706-71.099-86.336-0.446-0.016-0.229-0.24-0.2170.052-0.32363.7370000
Financing Activities:
Debt Repayment 0000000000073.6380000000
Common Stock Issued 242.708107.2729.6556.24314.5640.01200.0950.220.0690.333-0.933-0.776345.425242.7270000
Common Stock Repurchased 000000000000-0-0.01200000
Dividends Paid 0000000000000000000
Other Financing Activities 3.275-1.9590.8380.1180.180.01200.0890.2240.070.0740.296-0.296345.413241.8891.2850.07700
Financing Cash Flow 245.983105.31310.4936.37814.7440.01200.0890.2240.070.07473.001-1.072345.413242.7271.2850.07700
Other Information:
Effect Of Forex Changes On Cash -1.904-0.120.219-0.5040.220.3810.5180.722-0.438-0.268-0.434-1.6710.2653.352-0.0440.3550.491-0.06-0.861
Net Change In Cash 267.6549.154-9.812-43.46826.278-114.768-133.656-51.199-39.318-60.304-50.61716.267-41.202308.889291.385-1.641-1.327-1.875-4.5
Cash At End Of Period 395.026127.372118.218128.03171.498145.22259.988393.644444.843484.161544.465595.082578.815613.759298.6127.2278.86810.19512.07